title: Authors' reply to Liedgens and Henske: "cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective".
authors.affiliation: Medical Decison Modeling, Indianapolis, IN, USA, rwielage@mdm-inc.com.
authors.forename: Ronald C
authors.initials: RC
authors.lastname: Wielage
authors.forename: Megha
authors.initials: M
authors.lastname: Bansal
authors.forename: J Scott
authors.initials: JS
authors.lastname: Andrews
authors.forename: Robert W
authors.initials: RW
authors.lastname: Klein
authors.forename: Michael
authors.initials: M
authors.lastname: Happich
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008390:Markov Chains; D018803:Models, Economic; D010003:Osteoarthritis / Q000188:drug therapy* / Q000191:economics*; D013876:Thiophenes / Q000191:economics*
chemical_list: D013876:Thiophenes